I. Update of NIH Continuous Submission Policy: Change in Submission Deadlines and End of Recent Substantial Service Option NOT-OD-20-060
II. 6th Annual BRAIN Initiative Investigators Meeting, June 1-3, 2020,
III. Biomedical Data Repository (U24 – Clinical Trials Not Allowed) PAR-20-089
IV. Biomedical Knowledgebase (U24 – Clinical Trials Not Allowed) PAR-20-097
V. K99/R00 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity RFA-NS-19-043 (Clinical Trial Not Allowed) or RFA-NS-19-044 (Clinical Trial Required)
VI. Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed) PAR-18-789
I. Update of NIH Continuous Submission Policy: Change in Submission Deadlines and End of Recent Substantial Service Option NOT-OD-20-060
This Notice alerts the scientific research community of plans to discontinue the practice of granting one-year continuous submission status to reviewers with recent substantial review service, which was earned by serving 6 times in an 18 month period. NIH is deeply appreciative of those who regularly serve on our advisory groups. However, prior policy had unintended consequences, among them encouraging excessive review service and thus disproportionate influence by some. NIH believes that diverse advisory groups with a range of familiar and fresh voices best identify high impact research. Limiting over-utilization of the same reviewers on advisory groups is one step NIH is taking to address this goal. Implementation of this change is being done so as to honor commitments to those who have already served under the prior policy……. Please read rest of Notice: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-060.html
II. 6th Annual BRAIN Initiative Investigators Meeting, June 1-3, 2020,
Crystal Gateway Marriott, 1700 Richmond Hwy, Arlington, VA 22202
REGISTER HERE
The BRAIN Initiative® Investigators Meeting will convene BRAIN Initiative awardees, staff, and leadership from the contributing federal agencies (NIH, NSF, DARPA, IARPA, and FDA), plus representatives and investigators from participating non-federal organizations, and members of the media, public, and Congress. The purpose of this open meeting is to provide a forum for discussing exciting scientific developments and potential new directions, and to identify areas for collaboration and research coordination.
Federal BRAIN awardees should refer to their agency-specific email and/or federal project/program manager for additional instructions and details regarding participation in this meeting.
The target audience for this meeting includes:
- Federally funded and non-federally funded BRAIN Initiative investigators
- Non-federal organizations and groups invested in the BRAIN Initiative
BRAIN Initiative-related investigators at large - Federal staff
- Members of Congress
- Patient and advocacy groups
- Media and general public
III. Biomedical Data Repository (U24 – Clinical Trials Not Allowed) PAR-20-089
Application Due Date(s)
September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023.
AIDS Application Due Date(s)
January 7, 2021; May 7, 2021; January 7, 2022; May 6, 2022; January 6, 2023; May 8, 2023
All applications are due by 5:00 PM local time of applicant organization.
This funding opportunity announcement is designed to support biomedical data repositories. Biomedical data repositories under this announcement should have the primary function to ingest, archive, preserve, manage, distribute, and make accessible the data related to a particular system or systems. Support for data curation must be limited to that which improves the efficiency and accessibility of data ingestion, management, and use and reuse by the user communities. Support for software and tool development must be limited to that which provides essential functions or significantly increases the efficiency of operation of the repository. Applications that have a significant focus on software and tool development are not appropriate for this activity.
IV. Biomedical Knowledgebase (U24 – Clinical Trials Not Allowed) PAR-20-097
Application Due Date(s)
September 25, 2020; January 25, 2021; September 24, 2021; January 25, 2022; September 26, 2022; January 25, 2023.
AIDS Application Due Date(s)
January 7, 2021; May 7, 2021; January 7, 2022; May 6, 2022; January 6, 2023; May 8, 2023
All applications are due by 5:00 PM local time of applicant organization.
This funding opportunity announcement is designed to support biomedical knowledgebases. Biomedical knowledgebases under this announcement should have the primary function to extract, accumulate, organize, annotate, and link growing bodies of information related to core datasets. Support for data curation should include efficient and effective methods of curation that scale to the needs of the community and include semi-automated methods. Support for software and tool development must be limited to that which provides essential functions or significantly increases the efficiency of operation of the knowledgebase.
Applications that have a significant focus on software or tool development are not appropriate for this activity.
V. K99/R00 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity RFA-NS-19-043 (Clinical Trial Not Allowed) or RFA-NS-19-044 (Clinical Trial Required)
Inquiries from potential applicants from NIDA funded labs should be directed to Olivier.berton@nih.gov
There are two Funding Opportunity Announcements: One for clinical trials; one is not:
Upcoming due Dates for New Applications
February 10, 2020, June 10, 2020, October 9, 2020;
The BRAIN Initiative K99/R00 award is intended for individuals from diverse backgrounds (including nationally underrepresented groups) who have no more than five years of postdoctoral research experience and are working in all research areas supported by the BRAIN Initiative as highlighted in BRAIN 2025: A Scientific Vision ( including multidisciplinary areas at the interface of neuroscience and single-cell multiomics, neurotechnologies, bioengineering, computer science, statistics, mathematics, physics, chemistry and neuroethics).
Eligible individuals for this program will be U.S. citizens or permanent residents who fall in one of the categories defined in the Notice of NIH's Interest in Diversity. Women have been shown to be underrepresented in doctorate-granting research institutions at senior faculty levels in most biomedical-relevant disciplines by the National Science Foundation and for the purposes of this funding opportunity announcement are considered as eligible candidates for this diversity program.
VI. Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed) PAR-18-789
Application Due Date(s):
March 19, 2020; August 21, 2020, March 19, 2021, by 5:00 PM local time of applicant organization.
The goals of this initiative are to discover allelic variants, genomic alterations, and functional changes associated with addictive behaviors in non-human animals through systems studies that employ genetic and genomics strategies. We also encourage applications that take genetic and/or genomics approaches to integrate data, delineate gene networks, and uncover the function of known or newly discovered genetic or epigenetic variants.
Investigators examining the phenotype of knockout mice are discouraged from submitting applications to this FOA. Instead, they should submit applications in response PA-17-155 (R01) PA-17-157 (R21) Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders."
This FOA will replace PAR-15-120 "Identification of Genetic and Genomic Variants by Next-Gen Sequencing in Non-human Animal Models (U01)."
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
